putdeksel schreef op 4 maart 2024 20:06:
how many products does the firm vivoryon develop?
Vivoryon Therapeutics develops three therapeutic products. As of the end of 2022, their portfolio includes one product in phase II clinical development, Varoglutamstat (PQ912), and two products in the preclinical development phasehow long does the company exist?
Vivoryon Therapeutics AG, originally known as Probiodrug AG, has been in existence since 1997?has the company ever made any money?
As of the end of 2022, Vivoryon Therapeutics AG reported that it has not yet generated any revenue from the sale of products. The company's operations have been primarily funded through capital increases, issuing new shares, and entering into strategic partnerships and licensing agreementswhen was weber appointed?
Dr. Frank Weber was appointed as the CEO of Vivoryon Therapeutics in September 2023Redelijk deel management is vervangen vorig jaar zo lijkt het. Vorige groep executives verdiende 300k base en kreeg 700-900k share-based, geen idee welke terms maar dat is wellicht iets voor de BAFIN of de AFM om te bekijken (of ze gecashed hebben wetende dat het een lege huls was). Dit kan wel een smerig zaakje zijn/worden. Verder speculeren, ik heb niet heel veel research gedaan.